For IV/IM use only

Leobactum 1.5 logo

Cefoperazone + Sulbactam

Injection

Dual Support to Overcome Difficult Infections

Cefoperazone

Broad spectrum antibiotic therapy in gram +ve & -ve infections

Sulbactam

Acts as beta-lactamase inhibitor, thus restoring Cefoperazone activity against beta-lactamase producing strains

Indications

Respiratory Tract Infections
Urinary Tract Infections
Peritonitis
Cholecystitis
Cholangitis
Septicemia

Pelvic Inflammatory Diseases
Skin & Soft Tissue Inf.
Bone & Joint Inf.
Meningitis
Endometritis
Gonorrhea

Leobactum 1_5 Box
Leobactum 1.5 Injection Logo

Comparative Tolerability Index

Leobactum 1.5 Stats

The incidence of treatment-related adverse events was 6.5% and 16.4% in the cefoperazone-sulbactam and ceftazidimeamikacin-metronidazole groups, respectively, with more discontinuations due to treatment-related adverse events in the comparator arm (3.2% vs. 9.9%).

Surg Infect (Larchmt). 2008 Jun: 9(3) : 367-76

Higher Success Rates

Cefoperazone-Sulbactam has higher success rates than ceftazidime-amikacin-metronidazole (92.9% vs. 80.0%) in intra-abdominal infections.

Leobactum 1.5 Injection Logo

We’re here to help. Whether you’re looking for a Wholesale/Retail purchase, have any queries or just have feedback about Leobactum 1.5 Injection , you can also enquire about wholesale/retail purchase of Leobactum 1.5 Injection easily via Call /Email/filling out the form below